- Posts: 31
- Thank you received: 1
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Combining multiple studies, I found that the overall response rate to Dapsone is around 55%. And, it is often effective when nothing else works. Here is one such study:
onlinelibrary.wiley.com/doi/10.1002/ajh.22266/full
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab†
Francesco Zaja*, Luciana Marin, Marianna Chiozzotto, Simona Puglisi, Stefano Volpetti and Renato Fanin
If compared with [Rituximab and Nplate], dapsone is satisfactory as to toxicity. In this study, the incidence of hemolysis or methemoglobinemia was not significant and none of the patients experienced important side effects or interrupted therapy because of treatment intolerance. Other authors showed the development of reversible side effects requiring cessation of therapy in 2–10% of patients [4, 6].
In conclusion, dapsone appears to be a cheap medical alternative for patients with ITP and is active also in patients who failed previous rituximab therapy. The response is achieved in most cases after nearly 1 month of therapy, and it is generally maintained during therapy. Even if dapsone has a good safety profile, it is necessary to monitor the level of MHb and hemolysis particularly during the first weeks of therapy and to be aware of factors that may precipitate dapsone-induced methemoglobinemia as anemia, pneumonia, or lung diseases and to know how to manage this complication. A better comprehension of ITP pathophysiology and of dapsone mechanism of action will allow in the future a better and rational integration of this agent into the treatment algorithm of primary ITP.
Please Log in or Create an account to join the conversation.
pdsa.org/forum-sp-534/13-general-discussion-for-parents/28212-dapsone.html#42650
Dapsone will take a while to work, weeks or months. It's not used often and doesn't have a very good track record as far as success, but it does work once in a while.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003 | pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.
© Copyright 1997 - 2026, Platelet Disorder Support Association. All rights reserved.
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.